Detalhe da pesquisa
1.
RNA sequencing suggests that non-coding RNAs play a role in the development of acquired haemophilia.
J Cell Mol Med
; 27(13): 1790-1796, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317065
2.
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia.
J Cell Mol Med
; 27(19): 2864-2875, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37667538
3.
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy.
J Cell Mol Med
; 2021 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132464
4.
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.
Genome Res
; 28(4): 432-447, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567676
5.
Transforming growth factor ß-mediated micromechanics modulates disease progression in primary myelofibrosis.
J Cell Mol Med
; 24(19): 11100-11110, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32889753
6.
MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.
Cell Physiol Biochem
; 54(5): 994-1012, 2020 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33006449
7.
Transient leukemia of Down syndrome.
Crit Rev Clin Lab Sci
; 56(4): 247-259, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043105
8.
SERS assessment of the cancer-specific methylation pattern of genomic DNA: towards the detection of acute myeloid leukemia in patients undergoing hematopoietic stem cell transplantation.
Anal Bioanal Chem
; 411(29): 7907-7913, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745615
9.
Fibroblast dynamics as an in vitro screening platform for anti-fibrotic drugs in primary myelofibrosis.
J Cell Physiol
; 233(1): 422-433, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28294327
10.
Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches.
Crit Rev Clin Lab Sci
; 55(5): 329-345, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29801428
11.
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.
Crit Rev Clin Lab Sci
; 55(7): 501-515, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30238808
12.
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients.
Am J Hematol
; 93(1): 100-106, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29047144
13.
Non-Hodgkin lymphoma in Romania: a single-centre experience.
Hematol Oncol
; 35(2): 198-205, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26482423
14.
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
Br J Haematol
; 174(2): 218-26, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27061303
15.
The role of microRNAs in the pathogenesis of HIV-related lymphomas.
Crit Rev Clin Lab Sci
; 52(5): 232-41, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26218036
16.
The methylenetetrahydrofolate reductase (MTHFR) 677 C>T polymorphism increases the risk of developing chronic myeloid leukemia-a case-control study.
Tumour Biol
; 36(4): 3101-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25510667
17.
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.
Ann Hematol
; 94(7): 1081-92, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25900787
18.
MicroRNAs in liver malignancies. Basic science applied in surgery.
J BUON
; 20(2): 361-75, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26011324
19.
Modest contribution of JAK2 V617F allele burden to the occurrence of major thrombosis in polycthemia vera and essential thrombocythemia.
Blood Cells Mol Dis
; 73: 45-46, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249383
20.
Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma.
Blood Rev
; 61: 101100, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291017